JPRN-UMIN000009856已完成未知
To adjuvant chemotherapy after curative treatment of head and neck cancer A study of alternate-day administration definitive TS-1 - Phase II of the TS-1 every other day dosing regimen in head and neck cancer
ational Center for Global health and Medicine Otolarygology0 个研究点目标入组 55 人开始时间: 2013年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)It is contraindicated in patients with the administration of TS-1 2)Cases that are complicated by infection requiring treatment 3)Gastrointestinal disease with treatment (intestinal paralysis, intestinal obstruction, etc.) Patients with 4)Patients with interstitial pneumonitis or pulmonary fibrosis 5)Patients with diabetes 6)Patients with heart disease 7)Patients with (watery) diarrhea 8)Patients attending physician was deemed inappropriate as the subject of the study for other reasons
研究者
相似试验
招募中
不适用
Outcome of patients treated with chemotherapy and Radiation in Cervical Cancer.CTRI/2014/06/004699A50
已完成
2 期
Adjuvant chemotherapy for completely rsected non-small cell lung cancer with TS-1 - evaluation of predictive factors for prognosiscompletely resected non-small cell lung cancerJPRN-UMIN000001049Division of General Thoracic Surgery, Keio University, School of Medicine,200
进行中（未招募）
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
已完成
3 期
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
尚未招募
不适用
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224